TY - JOUR
T1 - The relationship between very high levels of serum high-density lipoprotein cholesterol and cause-specific mortality in a 20-year follow-up study of japanese general population
AU - The NIPPON DATA90 Research Group
AU - Hirata, Aya
AU - Okamura, Tomonori
AU - Sugiyama, Daisuke
AU - Kuwabara, Kazuyo
AU - Kadota, Aya
AU - Fujiyoshi, Akira
AU - Miura, Katsuyuki
AU - Okuda, Nagako
AU - Ohkubo, Takayoshi
AU - Okayama, Akira
AU - Ueshima, Hirotsugu
AU - Saitoh, Shigeyuki
AU - Sakata, Kiyomi
AU - Hozawa, Atsushi
AU - Hayakawa, Takehito
AU - Nakamura, Yoshikazu
AU - Nishi, Nobuo
AU - Kasagi, Fumiyoshi
AU - Murakami, Yoshitaka
AU - Izumi, Toru
AU - Matsumura, Yasuhiro
AU - Ojima, Toshiyuki
AU - Tamakoshi, Koji
AU - Nakagawa, Hideaki
AU - Kita, Yoshikuni
AU - Miyamatsu, Naomi
AU - Yoshita, Katsushi
AU - Miyamoto, Yoshihiro
AU - Kodama, Kazunori
AU - Kiyohara, Yutaka
N1 - Publisher Copyright:
© 2016, Japan Atherosclerosis Society. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Aims: There is no community-based cohort study to examine the effect of very high level of highdensity lipoprotein cholesterol (HDL-C) on coronary heart disease (CHD) and other cause-specific mortality. Therefore, we investigated the relationship between HDL-C including very high level and cause-specific mortality in a 20-year cohort study of the representative sample of Japanese. Methods: We followed 7,019 individuals from the Japanese general population (2,946 men and 4,073 women). We defined HDL-C levels as follow: low (HDL-C <1.04 mmol/L), reference (1.04-1.55 mmol/L), high (1.56- 2.06 mmol/L), very high (≥2.07 mmol/L). The multivariate adjusted hazard ratio (HR) for all-cause or cause-specific mortality was calculated using a Cox proportional hazards model adjusted for other traditional risk factors. Results: During follow-up, we observed 1,598 deaths. No significant association was observed between HDL-C and all-cause mortality. Serum HDL-C also showed no association with stroke. In contrast, the risk for CHD among high HDL-C was lower than reference, HRs were 0.51 [95% confidence interval (CI): 0.21-1.23] in men, 0.33 (95% CI: 0.11-0.95) in women, and 0.41 (95% CI: 0.21 -0.81) when men and women were combined. However, very high HDL-C did not show significant association with CHD and other cause-specific mortality. Conclusions: HDL-C was not associated with all-cause and stroke mortality. In contrast, high serum HDL-C levels, at least up to 2.06 mmol/L, were protective against CHD, although further high levels were not. However, sample size of cause-specific death in very high HDL-C group was not enough even in this 20-year follow-up of 7,019 Japanese; larger cohort studies should be warranted.
AB - Aims: There is no community-based cohort study to examine the effect of very high level of highdensity lipoprotein cholesterol (HDL-C) on coronary heart disease (CHD) and other cause-specific mortality. Therefore, we investigated the relationship between HDL-C including very high level and cause-specific mortality in a 20-year cohort study of the representative sample of Japanese. Methods: We followed 7,019 individuals from the Japanese general population (2,946 men and 4,073 women). We defined HDL-C levels as follow: low (HDL-C <1.04 mmol/L), reference (1.04-1.55 mmol/L), high (1.56- 2.06 mmol/L), very high (≥2.07 mmol/L). The multivariate adjusted hazard ratio (HR) for all-cause or cause-specific mortality was calculated using a Cox proportional hazards model adjusted for other traditional risk factors. Results: During follow-up, we observed 1,598 deaths. No significant association was observed between HDL-C and all-cause mortality. Serum HDL-C also showed no association with stroke. In contrast, the risk for CHD among high HDL-C was lower than reference, HRs were 0.51 [95% confidence interval (CI): 0.21-1.23] in men, 0.33 (95% CI: 0.11-0.95) in women, and 0.41 (95% CI: 0.21 -0.81) when men and women were combined. However, very high HDL-C did not show significant association with CHD and other cause-specific mortality. Conclusions: HDL-C was not associated with all-cause and stroke mortality. In contrast, high serum HDL-C levels, at least up to 2.06 mmol/L, were protective against CHD, although further high levels were not. However, sample size of cause-specific death in very high HDL-C group was not enough even in this 20-year follow-up of 7,019 Japanese; larger cohort studies should be warranted.
KW - Cohort studies
KW - High-density lipoprotein cholesterol
KW - Mortality
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=84976626396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84976626396&partnerID=8YFLogxK
U2 - 10.5551/jat.33449
DO - 10.5551/jat.33449
M3 - Article
C2 - 26923252
AN - SCOPUS:84976626396
SN - 1340-3478
VL - 23
SP - 800
EP - 809
JO - Journal of atherosclerosis and thrombosis
JF - Journal of atherosclerosis and thrombosis
IS - 7
ER -